Claim · 1953 · Cellular therapy (Frischzellentherapie)
Injection of fetal sheep cells from a specific organ restores the function and structure of the corresponding aging organ in the recipient through migration and integration of the donor cells.
The organ-specific migration claim is the central mechanistic assertion of the Niehans cellular-therapy protocol. No controlled investigation has demonstrated selective migration, durable integration, or restoration of a corresponding human organ. In 2015 Swissmedic and the Swiss Federal Office of Public Health described the Niehans procedure directly and reported that the efficacy of fresh-cell therapy had not been scientifically demonstrated.
Appears in
Sources
- Introduction to Cellular Therapy — Niehans, Paul. *Introduction to Cellular Therapy*. New York: Pageant Books, 1960.
- Measures against illegal fresh-cell therapy offers and unauthorized fresh-cell preparations — Federal Office of Public Health and Swissmedic. 'Massnahmen gegen illegale Therapieangebote mit Frischzellen und nicht zugelassenen Frischzellenpräparaten' [Measures against illegal fresh-cell therapy offers and unauthorized fresh-cell preparations]. Swissmedic Journal. 2015;03:188-193.